Skip to main content

Published locations for Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapse

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapse

User login

  • Reset your password
  • /content/farletuzumab-morab-003-platinum-sensitive-ovarian-cancer-patients-experiencing-first-relapse
  • /jcso/article/35251/gynecologic-cancer/farletuzumab-morab-003-platinum-sensitive-ovarian-cancer
  • /oncologypractice/article/35251/gynecologic-cancer/farletuzumab-morab-003-platinum-sensitive-ovarian
  • /hematology-oncology/article/35251/gynecologic-cancer/farletuzumab-morab-003-platinum-sensitive